Ginkgo Bioworks Statistics
NYSE: DNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
7.46-0.74 (-9.02%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ginkgo Bioworks by the numbers
Ginkgo Bioworks has a market capitalization of $483.5 million based on 53.94M shares outstanding. With trailing EPS of $-4.24, Ginkgo Bioworks is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.4% below its 50-day average and 13.5% below its 200-day average.
Average daily trading volume is 2.53M shares, or about $18.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DNA valuation vs. peer median
| Metric | DNA | Peer median | Difference |
|---|---|---|---|
| Market cap | $483.54M | $467.79M | +3% |
| Avg. volume | 2.53M | 390.07K | +548% |
Peer median across 8 companies: SANA, VALN, RGNX, FENC, ETRA, IRLA, PROK, TECX.
Valuation
- Market cap
- $483.54M
- Price / sales (latest FY)
- 2.84
- EPS (TTM)
- $-4.24
- Shares outstanding
- 53.94M
Price and trading
- Previous close
- 8.20
- Open
- 7.93
- Day range
- 7.39 – 8.28
- 52-week range
- 5.37 – 18.22
- 52-week change
- -8.69%
- Beta
- —
- Volume
- 2.50M
- Average volume
- 2.53M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 483.54M
- Forward Pe
- -2.57
- Eps
- -4.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.22
- Week52 Low
- 5.37
- Avg Volume
- 2.53M
- Shares Outstanding
- 53.94M
- Ma50
- 10.42
- Ma200
- 8.63
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -59.06%
- Pct From52w Low
- 38.92%